Journal: BMC Cancer
Article Title: Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b
doi: 10.1186/s12885-024-12490-5
Figure Lengend Snippet: SOX2 suppression mediated ISO-induced SNHG1 downregulation in BMIBC cells. (A) Wild-type SNHG1 promoter-driven luciferase reporter was cotransfected with pRL-TK into 5637 or UM-UC-3 cells; luciferase activity was measured 24 h post-transfection. TK served as an internal control. *Significantly different from the control group, p < 0.05. (B) Predicted transcription factor-binding sites in the SNHG1 promoter. (C) Transcription factor expression in 5637 cells treated with ISO at indicated times. (D) Schematic of SOX2 binding site in wild-type and mutant SNHG1 promoters. (E) 5637 cells cotransfected with wild-type or mutant SNHG1 promoter reporters and pRL-TK. (F) Western blot analysis of SOX2 expression in 5637 (SOX2) and 5637 (Vector) cells; GAPDH as control. (G) Western blot analysis of indicated proteins in cells with/without ISO treatment; GAPDH for normalization. (H) Relative SNHG1 levels in 5637 (SOX2) and 5637 (Vector) cells with 20 µM ISO or 0.1% DMSO were assessed by RT-qPCR. (I & J) Invasion abilities of 5637 (Vector) and 5637 (SOX2) cells with 20 µM ISO or 0.1% DMSO (I); relative invasion plotted (J). * p < 0.05, # p < 0.05, ♣ p < 0.05 vs. respective controls. (K & L) Colonies of 5637 (SOX2) and 5637 (Vector) cells in soft agar with 20 µM ISO or 0.1% DMSO (K). Colony counts shown in (L). * p < 0.05, # p < 0.05, ♣ p < 0.05 vs. respective controls
Article Snippet: The SOX2 overexpression construct pSin-EF2-SOX2 and the Myc-DNMT3b overexpression construct were purchased from Addgene (Cambridge, MA, USA).
Techniques: Luciferase, Activity Assay, Transfection, Control, Binding Assay, Expressing, Mutagenesis, Western Blot, Plasmid Preparation, Quantitative RT-PCR